PMID: 12162817

Wagner JA, Nepomuceno IB, Messner AH, Moran ML, Batson EP, Dimiceli S, Brown BW, Desch JK, Norbash AM, Conrad CK, Guggino WB, Flotte TR, Wine JJ, Carter BJ, Reynolds TC, Moss RB, Gardner P
A phase II, double-blind, randomized, placebo-controlled clinical trial of tgAAVCF using maxillary sinus delivery in patients with cystic fibrosis with antrostomies.
Hum Gene Ther. 2002 Jul 20;13(11):1349-59., 2002-07-20 [PubMed]
Sentences
No. Mutations Sentence Comment
157 ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 12162817:157:258
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Arg334Trp
X
ABCC7 p.Arg334Trp 12162817:157:247
status: NEW
view ABCC7 p.Arg334Trp details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 12162817:157:142
status: NEW
view ABCC7 p.Gly542* details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 12162817:157:284
status: NEW
view ABCC7 p.Gly542* details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 12162817:157:241
status: NEW
view ABCC7 p.Gly85Glu details
Of the 23 treated patients, 11 were homozygous for DF508, 3 were DF508 heterozygouswith an unidentifiedallele, 2 were DF508 heterozygous with G542X, 6 were DF508 heterozygous with another allele (one each of 3849110KB, 3905 insert T, 62111, G85E, R334W, and W1282X) and 1 patient was G542X heterozygous with an unidentified allele. Login to comment